Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01646723
Other study ID # VALID1
Secondary ID
Status Completed
Phase N/A
First received July 18, 2012
Last updated April 13, 2017
Start date June 2012
Est. completion date March 2016

Study information

Verified date April 2017
Source Queen's University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The objectives of our project are to: 1.) Develop a training program and manual for volunteers to implement evidence-based, non-pharmacological interventions for neuropsychiatric symptoms (NPS) of dementia in long-term care (LTC) settings; 2.) Recruit and train volunteers using the VALID program and pilot test the volunteer-led program with 20 individuals with Alzheimer's disease and NPS in a LTC facility in Kingston; and, 3.) Evaluate the effects of the VALID program on the symptoms of NPS, patient quality of life, volunteer's experience, and LTC staff stress.


Recruitment information / eligibility

Status Completed
Enrollment 75
Est. completion date March 2016
Est. primary completion date December 2015
Accepts healthy volunteers No
Gender All
Age group 65 Years and older
Eligibility Inclusion Criteria:

- diagnosis of Alzheimer's disease or related forms of dementia

- significant symptoms of agitation as measured by a Cohen-Mansfield Agitation Inventory (CMAI) total score of >39

- in nursing home for at least 30 days

- presence of a caregiver or substitute decision maker willing to consent to treatment

- no changes in psychotropic medications in the 2 weeks preceding enrolment in study

Exclusion Criteria:

- depressive symptoms presenting risk

- physically aggressive behavior posing safety risk to others

- uncontrolled pain

- currently receiving palliative care

- medically unstable with life expectancy of < 6 months

- currently awaiting transfer to another LTC facility or hospital.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Volunteers Adding Life in Dementia (VALID) Program
The VALID intervention will consist of 2 phases. First, volunteers will complete an assessment involving recording of a "Life Story" for each patient participant. This will include information on the patient's psychosocial history, occupational history, hobbies, interests and preferred activities using information from the LTC medical record and interviews with the patient and family members. Based on this information, a variety of potential psychosocial interventions will be developed for the individual with the assistance of the recreation therapist at the LTC. The second phase will involve implementation of the VALID intervention. Each individual with dementia will receive personalized pleasant activities for a minimum session of 30 minutes at a frequency of 3 times per week. One volunteer will complete the "Life Story" assessment and up to 3 volunteers may be involved with implementing the VALID program for each resident.

Locations

Country Name City State
Canada Extendicare Kingston Kingston Ontario

Sponsors (1)

Lead Sponsor Collaborator
Queen's University

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Cohen-Mansfield Agitation Inventory (CMAI) score Baseline and 12 weeks
Secondary Clinically significant reduction in agitation 30% reduction in CMAI score Baseline and 12 weeks
Secondary Remission of neuropsychiatric symptoms CMAI score <40 Baseline and 12 weeks
Secondary Change in Neuropsychiatric Inventory (NPI) score Baseline and 12 weeks
Secondary Change in depression symptoms (Cornell Depression in Dementia Rating Scale) Baseline and 12 weeks
Secondary Dementia Quality of Life (DemQoL) Scale Baseline and 12 weeks
Secondary Clinical Global Impression of Change (CGI-C) Baseline and 12 weeks
Secondary Use and dose of required medication Baseline and 12 weeks
Secondary Short form health survey Volunteer quality of life Baseline and 12 weeks
Secondary Change in Modified Nursing Care Assessment Scale score Assessing nursing stress. Baseline and 12 weeks
See also
  Status Clinical Trial Phase
Completed NCT04044495 - Sleep, Rhythms and Risk of Alzheimer's Disease N/A
Completed NCT04079803 - PTI-125 for Mild-to-moderate Alzheimer's Disease Patients Phase 2
Terminated NCT03052712 - Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies N/A
Recruiting NCT04520698 - Utilizing Palliative Leaders In Facilities to Transform Care for Alzheimer's Disease N/A
Active, not recruiting NCT04606420 - Can Lifestyle Changes Reverse Early-Stage Alzheimer's Disease N/A
Recruiting NCT05820919 - Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase N/A
Terminated NCT03672474 - REGEnLIFE RGn530 - Feasibility Pilot N/A
Completed NCT03430648 - Is Tau Protein Linked to Mobility Function?
Recruiting NCT05288842 - Tanycytes in Alzheimer's Disease and Frontotemporal Dementia
Recruiting NCT05557409 - A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease Agitation Phase 3
Recruiting NCT04522739 - Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Alzheimer's Disease Phase 4
Recruiting NCT04949750 - Efficacy of Paper-based Cognitive Training in Vietnamese Patients With Early Alzheimer's Disease N/A
Completed NCT06194552 - A Multiple Dose Study of the Safety and Pharmacokinetics of NTRX-07 Phase 1
Completed NCT03239561 - Evaluation of Tau Protein in the Brain of Participants With Alzheimer's Disease Compared to Healthy Participants Early Phase 1
Completed NCT03184467 - Clinical Trial to Evaluate the Efficacy and Safety of GV1001 in Alzheimer Patients Phase 2
Active, not recruiting NCT03676881 - Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
Terminated NCT03487380 - Taxonomic and Functional Composition of the Intestinal Microbiome: a Predictor of Rapid Cognitive Decline in Patients With Alzheimer's Disease N/A
Completed NCT05538455 - Investigating ProCare4Life Impact on Quality of Life of Elderly Subjects With Neurodegenerative Diseases N/A
Recruiting NCT05328115 - A Study on the Safety, Tolerability and Immunogenicity of ALZ-101 in Participants With Early Alzheimer's Disease Phase 1
Completed NCT05562583 - SAGE-LEAF: Reducing Burden in Alzheimer's Disease Caregivers Through Positive Emotion Regulation and Virtual Support N/A